By inhibiting CDK4 and CDK6, p16ink4a ensures that the RB1 protein remains in its active, hypophosphorylated state. This prevents the cell from progressing from the G1 phase to the S phase of the cell cycle, effectively halting cell division. This mechanism is crucial for the prevention of uncontrolled cell proliferation, a hallmark of cancer.
